Cargando…
Is It Time to Reassess the Role of Radiotherapy Treatment in Ovarian Cancer?
With a 5-year survival rate of fewer than 50%, epithelial ovarian carcinoma is the most fatal of the gynecologic cancers. Each year, an estimated 22,000 women are diagnosed with the condition, with 14,000 dying as a result, in the United States. Over the last decade, the advent of molecular and gene...
Autores principales: | Macchia, Gabriella, Titone, Francesca, Restaino, Stefano, Arcieri, Martina, Pellecchia, Giulia, Andreetta, Claudia, Driul, Lorenza, Vizzielli, Giuseppe, Pezzulla, Donato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486999/ https://www.ncbi.nlm.nih.gov/pubmed/37685447 http://dx.doi.org/10.3390/healthcare11172413 |
Ejemplares similares
-
CUP-syndrome: Inguinal high grade serous ovarian carcinoma lymph node metastases with unknown primary origin – a case report and literature review
por: Restaino, Stefano, et al.
Publicado: (2022) -
A Rare Case of Hepatocellular Carcinoma Recurrence in Ovarian Site after 12 Years Mimicking a Hepatoid Adenocarcinoma: Case Report
por: Restaino, Stefano, et al.
Publicado: (2023) -
Mesonephric-Like Adenocarcinomas a Rare Tumor: The Importance of Diagnosis
por: Restaino, Stefano, et al.
Publicado: (2022) -
Scar-Free Laparoscopy in BRCA-Mutated Women
por: Restaino, Stefano, et al.
Publicado: (2022) -
Fiducial markers in adjuvant setting for a patient affected by endometrial cancer: a case report
por: Titone, Francesca, et al.
Publicado: (2023)